Equivocal vs Positive Technetium-99m-Pyrophosphate Scintigraphy for Transthyretin Amyloid Cardiomyopathy: Comparing Outcomes, Demographics, and Imaging. [PDF]
Chai J +8 more
europepmc +1 more source
Technetium-99m-Labeled Fibroblast Activation Protein-Targeted Nanobody Radiotracer: from Preclinical Development to Clinical Translation in Cancer Imaging. [PDF]
Li C +6 more
europepmc +1 more source
Biomarkers to Predict Abnormal Technetium-99m Pyrophosphate Scans in Patients With Suspected Transthyretin Amyloidosis. [PDF]
De Michieli L +9 more
europepmc +1 more source
Radiolabeling of bionanomaterials with technetium 99m: current state and future prospects. [PDF]
Trusova V +6 more
europepmc +1 more source
Predictive value of technetium-99m sodium pertechnetate thyroid scintigraphy in determining the permanence of congenital hypothyroidism. [PDF]
Li WI, Chan TK, Ng KK, Kung BT.
europepmc +1 more source
Renal clearance estimated by rubidium-82 positron emission tomography/computed tomography and technetium-99m-mercaptoacetyltriglycine clearance infusion technique. [PDF]
Langaa SS +7 more
europepmc +1 more source
Clinical Implications of the Washout Phenomenon in Technetium-99m (99mTc-) Labeled Compounds for Myocardial Perfusion Imaging. [PDF]
Taniguchi Y.
europepmc +1 more source
Incidental Extracardiac Findings of Technetium-99m Pyrophosphate Scintigraphy: A Pictorial Review. [PDF]
Fathala AL.
europepmc +1 more source
Rethinking Thin-Layer Chromatography for Screening Technetium-99m Radiolabeled Polymer Nanoparticles. [PDF]
Schorr K +6 more
europepmc +1 more source
Development of [99mTc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer. [PDF]
Lis C +12 more
europepmc +1 more source

